US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 21.150
  • +0.390+1.88%
Close May 2 16:00 ET
  • 21.150
  • 0.0000.00%
Post 16:20 ET
1.88BMarket Cap-7.58P/E (TTM)

Travere Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
97.54%81.73M
60.55%233.18M
65.98%74.79M
69.56%62.9M
68.08%54.12M
33.95%41.37M
32.69%145.24M
53.58%45.06M
32.13%37.1M
-40.56%32.2M
Operating revenue
97.54%81.73M
60.55%233.18M
65.98%74.79M
69.56%62.9M
68.08%54.12M
33.95%41.37M
32.69%145.24M
53.58%45.06M
32.13%37.1M
-40.56%32.2M
Cost of revenue
211.10%4.68M
-32.37%7.74M
-44.06%2.55M
26.14%1.63M
41.94%2.06M
-63.72%1.5M
159.05%11.45M
425.81%4.56M
15.71%1.29M
-29.21%1.45M
Gross profit
93.26%77.05M
68.50%225.43M
78.38%72.23M
71.12%61.27M
69.32%52.06M
49.09%39.87M
27.37%133.79M
42.23%40.5M
32.81%35.81M
-41.01%30.74M
Operating expense
-33.06%119.73M
7.11%546.82M
6.68%131.57M
-8.64%117.3M
-11.57%119.11M
44.10%178.85M
20.17%510.53M
7.09%123.33M
17.18%128.39M
19.56%134.7M
Selling and administrative expenses
13.41%72.84M
-0.54%264.12M
9.30%69.5M
-3.22%65.62M
-5.02%64.78M
-2.62%64.22M
34.44%265.54M
11.39%63.59M
29.34%67.8M
28.74%68.2M
-General and administrative expense
13.41%72.84M
-0.54%264.12M
9.30%69.5M
-3.22%65.62M
-5.02%64.78M
-2.62%64.22M
34.44%265.54M
11.39%63.59M
29.34%67.8M
--68.2M
Research and development costs
-59.09%46.89M
15.39%282.7M
3.88%62.07M
-14.71%51.68M
-18.29%54.33M
97.08%114.63M
7.77%244.99M
2.86%59.75M
6.03%60.59M
11.41%66.49M
Operating profit
69.29%-42.67M
14.69%-321.39M
28.37%-59.33M
39.49%-56.03M
35.50%-67.05M
-42.73%-138.98M
-17.80%-376.74M
4.46%-82.84M
-12.08%-92.59M
-71.69%-103.95M
Net non-operating interest income expense
-70.98%938K
-36.41%6.64M
-77.42%978K
-73.75%793K
-28.58%1.63M
306.03%3.23M
320.22%10.43M
1,585.21%4.33M
514.97%3.02M
204.34%2.29M
Non-operating interest income
-37.09%3.8M
-18.15%17.82M
-46.94%3.8M
-38.89%3.57M
-13.81%4.42M
65.44%6.03M
246.85%21.77M
129.60%7.15M
178.06%5.84M
555.75%5.13M
Non-operating interest expense
2.04%2.86M
-1.34%11.18M
-0.14%2.82M
-1.56%2.78M
-1.93%2.79M
-1.75%2.8M
2.91%11.33M
-1.29%2.82M
-0.28%2.82M
-4.34%2.84M
Other net income (expense)
2,714.29%549K
41.27%-5.76M
80.20%-1.98M
18.51%397K
-1,963.68%-4.15M
-124.14%-21K
-48.39%-9.8M
-1,249.08%-10.02M
157.17%335K
95.27%-201K
Special income (charges)
--0
78.60%-2.44M
87.69%-1.4M
---123K
---653K
---259K
-50.36%-11.39M
---11.39M
--0
--0
-Less：Restructuring and merger&acquisition
--0
-78.60%2.44M
-87.69%1.4M
--123K
--653K
--259K
--11.39M
--11.39M
--0
--0
Other non- operating income (expenses)
130.67%549K
-308.16%-3.32M
-142.29%-581K
55.22%520K
-1,638.81%-3.5M
173.56%238K
63.66%1.59M
57.57%1.37M
157.17%335K
-130.36%-201K
Income before tax
69.66%-41.19M
14.78%-320.51M
31.84%-60.34M
38.54%-54.84M
31.71%-69.57M
-40.71%-135.77M
-13.58%-376.11M
-3.45%-88.53M
-6.33%-89.23M
-52.09%-101.87M
Income tax
-79.58%39K
-46.19%120K
-205.88%-72K
-800.00%-84K
30.77%85K
144.87%191K
-28.75%223K
7.94%68K
-91.72%12K
22.64%65K
Net income
69.70%-41.23M
-188.64%-321.55M
33.17%-60.26M
-136.36%-54.81M
17.78%-70.41M
-57.60%-136.06M
60.00%-111.4M
-36.99%-90.17M
316.40%150.74M
-27.74%-85.63M
Net income continuous Operations
69.68%-41.23M
14.80%-320.63M
31.97%-60.27M
38.65%-54.75M
31.67%-69.65M
-40.80%-135.96M
-13.54%-376.33M
-3.46%-88.6M
-6.16%-89.24M
-52.06%-101.93M
Net income discontinuous operations
--0
-100.35%-915K
100.25%4K
-100.02%-59K
-104.64%-757K
-101.01%-103K
400.01%264.93M
-107.96%-1.58M
1,565.69%239.98M
--16.3M
Minority interest income
Net income attributable to the parent company
69.70%-41.23M
-188.64%-321.55M
33.17%-60.26M
-136.36%-54.81M
17.78%-70.41M
-57.60%-136.06M
60.00%-111.4M
-36.99%-90.17M
316.40%150.74M
-27.74%-85.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
69.70%-41.23M
-188.64%-321.55M
33.17%-60.26M
-136.36%-54.81M
17.78%-70.41M
-57.60%-136.06M
60.00%-111.4M
-36.99%-90.17M
316.40%150.74M
-27.74%-85.63M
Basic earnings per share
73.30%-0.47
-172.00%-4.08
38.14%-0.73
-135.53%-0.7
19.47%-0.91
-38.58%-1.76
65.68%-1.5
-14.56%-1.18
280.73%1.97
-7.62%-1.13
Diluted earnings per share
73.30%-0.47
-172.00%-4.08
38.14%-0.73
-135.53%-0.7
19.47%-0.91
-38.58%-1.76
65.68%-1.5
-14.56%-1.18
280.73%1.97
-7.62%-1.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 97.54%81.73M60.55%233.18M65.98%74.79M69.56%62.9M68.08%54.12M33.95%41.37M32.69%145.24M53.58%45.06M32.13%37.1M-40.56%32.2M
Operating revenue 97.54%81.73M60.55%233.18M65.98%74.79M69.56%62.9M68.08%54.12M33.95%41.37M32.69%145.24M53.58%45.06M32.13%37.1M-40.56%32.2M
Cost of revenue 211.10%4.68M-32.37%7.74M-44.06%2.55M26.14%1.63M41.94%2.06M-63.72%1.5M159.05%11.45M425.81%4.56M15.71%1.29M-29.21%1.45M
Gross profit 93.26%77.05M68.50%225.43M78.38%72.23M71.12%61.27M69.32%52.06M49.09%39.87M27.37%133.79M42.23%40.5M32.81%35.81M-41.01%30.74M
Operating expense -33.06%119.73M7.11%546.82M6.68%131.57M-8.64%117.3M-11.57%119.11M44.10%178.85M20.17%510.53M7.09%123.33M17.18%128.39M19.56%134.7M
Selling and administrative expenses 13.41%72.84M-0.54%264.12M9.30%69.5M-3.22%65.62M-5.02%64.78M-2.62%64.22M34.44%265.54M11.39%63.59M29.34%67.8M28.74%68.2M
-General and administrative expense 13.41%72.84M-0.54%264.12M9.30%69.5M-3.22%65.62M-5.02%64.78M-2.62%64.22M34.44%265.54M11.39%63.59M29.34%67.8M--68.2M
Research and development costs -59.09%46.89M15.39%282.7M3.88%62.07M-14.71%51.68M-18.29%54.33M97.08%114.63M7.77%244.99M2.86%59.75M6.03%60.59M11.41%66.49M
Operating profit 69.29%-42.67M14.69%-321.39M28.37%-59.33M39.49%-56.03M35.50%-67.05M-42.73%-138.98M-17.80%-376.74M4.46%-82.84M-12.08%-92.59M-71.69%-103.95M
Net non-operating interest income expense -70.98%938K-36.41%6.64M-77.42%978K-73.75%793K-28.58%1.63M306.03%3.23M320.22%10.43M1,585.21%4.33M514.97%3.02M204.34%2.29M
Non-operating interest income -37.09%3.8M-18.15%17.82M-46.94%3.8M-38.89%3.57M-13.81%4.42M65.44%6.03M246.85%21.77M129.60%7.15M178.06%5.84M555.75%5.13M
Non-operating interest expense 2.04%2.86M-1.34%11.18M-0.14%2.82M-1.56%2.78M-1.93%2.79M-1.75%2.8M2.91%11.33M-1.29%2.82M-0.28%2.82M-4.34%2.84M
Other net income (expense) 2,714.29%549K41.27%-5.76M80.20%-1.98M18.51%397K-1,963.68%-4.15M-124.14%-21K-48.39%-9.8M-1,249.08%-10.02M157.17%335K95.27%-201K
Special income (charges) --078.60%-2.44M87.69%-1.4M---123K---653K---259K-50.36%-11.39M---11.39M--0--0
-Less：Restructuring and merger&acquisition --0-78.60%2.44M-87.69%1.4M--123K--653K--259K--11.39M--11.39M--0--0
Other non- operating income (expenses) 130.67%549K-308.16%-3.32M-142.29%-581K55.22%520K-1,638.81%-3.5M173.56%238K63.66%1.59M57.57%1.37M157.17%335K-130.36%-201K
Income before tax 69.66%-41.19M14.78%-320.51M31.84%-60.34M38.54%-54.84M31.71%-69.57M-40.71%-135.77M-13.58%-376.11M-3.45%-88.53M-6.33%-89.23M-52.09%-101.87M
Income tax -79.58%39K-46.19%120K-205.88%-72K-800.00%-84K30.77%85K144.87%191K-28.75%223K7.94%68K-91.72%12K22.64%65K
Net income 69.70%-41.23M-188.64%-321.55M33.17%-60.26M-136.36%-54.81M17.78%-70.41M-57.60%-136.06M60.00%-111.4M-36.99%-90.17M316.40%150.74M-27.74%-85.63M
Net income continuous Operations 69.68%-41.23M14.80%-320.63M31.97%-60.27M38.65%-54.75M31.67%-69.65M-40.80%-135.96M-13.54%-376.33M-3.46%-88.6M-6.16%-89.24M-52.06%-101.93M
Net income discontinuous operations --0-100.35%-915K100.25%4K-100.02%-59K-104.64%-757K-101.01%-103K400.01%264.93M-107.96%-1.58M1,565.69%239.98M--16.3M
Minority interest income
Net income attributable to the parent company 69.70%-41.23M-188.64%-321.55M33.17%-60.26M-136.36%-54.81M17.78%-70.41M-57.60%-136.06M60.00%-111.4M-36.99%-90.17M316.40%150.74M-27.74%-85.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 69.70%-41.23M-188.64%-321.55M33.17%-60.26M-136.36%-54.81M17.78%-70.41M-57.60%-136.06M60.00%-111.4M-36.99%-90.17M316.40%150.74M-27.74%-85.63M
Basic earnings per share 73.30%-0.47-172.00%-4.0838.14%-0.73-135.53%-0.719.47%-0.91-38.58%-1.7665.68%-1.5-14.56%-1.18280.73%1.97-7.62%-1.13
Diluted earnings per share 73.30%-0.47-172.00%-4.0838.14%-0.73-135.53%-0.719.47%-0.91-38.58%-1.7665.68%-1.5-14.56%-1.18280.73%1.97-7.62%-1.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DexCom
DXCM
81.620
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
11.660
New Fortress Energy
NFE
6.080
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.310
5
Enerpac Tool
EPAC
41.900
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.